BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36793057)

  • 41. The gut mycobiome of the Human Microbiome Project healthy cohort.
    Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
    Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut mycobiome dysbiosis and its impact on intestinal permeability in attention-deficit/hyperactivity disorder.
    Wang LJ; Li SC; Yeh YM; Lee SY; Kuo HC; Yang CY
    J Child Psychol Psychiatry; 2023 Sep; 64(9):1280-1291. PubMed ID: 37016804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma.
    Lapidot Y; Amir A; Nosenko R; Uzan-Yulzari A; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Safran M; Ben-Ari Z
    mSystems; 2020 Jun; 5(3):. PubMed ID: 32546668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy.
    Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Pietrzak B; Schmidt M; Galus Ł; Mackiewicz J; Mackiewicz A; Kozlowski P; Philips A
    Cancer Immunol Res; 2024 Apr; 12(4):427-439. PubMed ID: 38315788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors.
    Zhang L; Chai D; Chen C; Li C; Qiu Z; Kuang T; Parveena M; Dong K; Yu J; Deng W; Wang W
    Front Microbiol; 2022; 13():946995. PubMed ID: 35910636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intestinal
    Liu Z; Li Y; Li C; Lei G; Zhou L; Chen X; Jia X; Lu Y
    Front Microbiol; 2022; 13():812771. PubMed ID: 35369462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer.
    Alam A; Levanduski E; Denz P; Villavicencio HS; Bhatta M; Alhorebi L; Zhang Y; Gomez EC; Morreale B; Senchanthisai S; Li J; Turowski SG; Sexton S; Sait SJ; Singh PK; Wang J; Maitra A; Kalinski P; DePinho RA; Wang H; Liao W; Abrams SI; Segal BH; Dey P
    Cancer Cell; 2022 Feb; 40(2):153-167.e11. PubMed ID: 35120601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Candida albicans Enhances the Progression of Oral Squamous Cell Carcinoma
    Vadovics M; Ho J; Igaz N; Alföldi R; Rakk D; Veres É; Szücs B; Horváth M; Tóth R; Szücs A; Csibi A; Horváth P; Tiszlavicz L; Vágvölgyi C; Nosanchuk JD; Szekeres A; Kiricsi M; Henley-Smith R; Moyes DL; Thavaraj S; Brown R; Puskás LG; Naglik JR; Gácser A
    mBio; 2021 Feb; 13(1):e0314421. PubMed ID: 35089096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts.
    Liu NN; Jiao N; Tan JC; Wang Z; Wu D; Wang AJ; Chen J; Tao L; Zhou C; Fang W; Cheong IH; Pan W; Liao W; Kozlakidis Z; Heeschen C; Moore GG; Zhu L; Chen X; Zhang G; Zhu R; Wang H
    Nat Microbiol; 2022 Feb; 7(2):238-250. PubMed ID: 35087227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer.
    Deng T; Li J; He B; Chen B; Liu F; Chen Z; Zheng J; Shi Z; Zhang T; Deng L; Yu H; Yang J; Wu L; Shan Y; Yu Z; Chen X; Wang Y; Chen G
    Hepatol Int; 2022 Feb; 16(1):99-111. PubMed ID: 35064546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Roles for the mycobiome in liver disease.
    Zeng S; Schnabl B
    Liver Int; 2022 Apr; 42(4):729-741. PubMed ID: 34995410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fungal dysbiosis of the gut microbiota is associated with colorectal cancer in Chinese patients.
    Wang Y; Ren Y; Huang Y; Yu X; Yang Y; Wang D; Shi L; Tao K; Wang G; Wu K
    Am J Transl Res; 2021; 13(10):11287-11301. PubMed ID: 34786058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy.
    Shiao SL; Kershaw KM; Limon JJ; You S; Yoon J; Ko EY; Guarnerio J; Potdar AA; McGovern DPB; Bose S; Dar TB; Noe P; Lee J; Kubota Y; Maymi VI; Davis MJ; Henson RM; Choi RY; Yang W; Tang J; Gargus M; Prince AD; Zumsteg ZS; Underhill DM
    Cancer Cell; 2021 Sep; 39(9):1202-1213.e6. PubMed ID: 34329585
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Zhong M; Xiong Y; Zhao J; Gao Z; Ma J; Wu Z; Song Y; Hong X
    Theranostics; 2021; 11(10):4945-4956. PubMed ID: 33754037
    [No Abstract]   [Full Text] [Related]  

  • 55. Fungal-induced glycolysis in macrophages promotes colon cancer by enhancing innate lymphoid cell secretion of IL-22.
    Zhu Y; Shi T; Lu X; Xu Z; Qu J; Zhang Z; Shi G; Shen S; Hou Y; Chen Y; Wang T
    EMBO J; 2021 Jun; 40(11):e105320. PubMed ID: 33591591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut Microbial Signature of Hepatocellular Cancer in Men With Cirrhosis.
    Albhaisi S; Shamsaddini A; Fagan A; McGeorge S; Sikaroodi M; Gavis E; Patel S; Davis BC; Acharya C; Sterling RK; Matherly S; Fuchs M; Gillevet PM; Bajaj JS
    Liver Transpl; 2021 May; 27(5):629-640. PubMed ID: 33492761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fecal Fungi Dysbiosis in Nonalcoholic Fatty Liver Disease.
    You N; Xu J; Wang L; Zhuo L; Zhou J; Song Y; Ali A; Luo Y; Yang J; Yang W; Zheng M; Xu J; Shao L; Shi J
    Obesity (Silver Spring); 2021 Feb; 29(2):350-358. PubMed ID: 33491316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma.
    Behary J; Amorim N; Jiang XT; Raposo A; Gong L; McGovern E; Ibrahim R; Chu F; Stephens C; Jebeili H; Fragomeli V; Koay YC; Jackson M; O'Sullivan J; Weltman M; McCaughan G; El-Omar E; Zekry A
    Nat Commun; 2021 Jan; 12(1):187. PubMed ID: 33420074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New advances in the diagnosis and management of hepatocellular carcinoma.
    Yang JD; Heimbach JK
    BMJ; 2020 Oct; 371():m3544. PubMed ID: 33106289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.